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ABSTRACT
Magnetic stimulation has been applied to bone regeneration, however, the cellular and molecular mechanisms of repair still
require a better understanding. A three-dimensional (3D) collagen model was developed using plastic compression, which
produces dense, cellular, mechanically strong native collagen structures. Osteoblast cells (MG-63) and magnetic iron oxide
nanoparticles (IONPs) were incorporated into collagen gels to produce a range of cell-laden models. A magnetic bio-reactor
to support cell growth under static magnetic fields (SMFs) was designed and fabricated by 3D printing. The influences of
SMFs on cell proliferation, differentiation, extracellular matrix production, mineralisation and gene expression were evaluated.
Polymerase chain reaction (PCR) further determined the effects of SMFs on the expression of runt-related transcription factor 2
(Runx2), osteonectin (ON), and bone morphogenic proteins 2 and 4 (BMP-2 and BMP-4). Results demonstrate that SMFs,
IONPs and the collagen matrix can stimulate the proliferation, alkaline phosphatase production and mineralisation of MG-63
cells, by influencing matrix/cell interactions and encouraging the expression of Runx2, ON, BMP-2 and BMP-4. Therefore, the
collagen model developed here not only offers a novel 3D bone model to better understand the effect of magnetic stimulation
on osteogenesis, but also paves the way for further applications in tissue engineering and regenerative medicine.
Introduction
Every year, approximately 850,000 patients suffer from bone fracture in the UK. The rate of non-union is suggested to be
5-10%, and the cost to the National Health Service (NHS) of treating non-union has been reported to range between £7,000 and
£79,000 per person1, which has a substantial economic and quality of life impact. Bone regeneration is a physiologic process
that replaces the injured bone with new bone thereby renewing the biological and mechanical properties of the injured site. It is
a complicated metabolic process, which requires the interaction of many factors, including growth and differentiation factors,
hormones, cytokines, and extracellular components. If these factors are inadequate or interrupted, healing will be delayed or
impaired, resulting in non-union of the bone.
For more than a century, investigators have been developing alternative treatments that have aimed to resolve the bone
fracture healing process, by physical or biological methods. The physical strategy includes the use of mechanical stimulation2,
electrical stimulation3, electromagnetic stimulation4, and magnetic stimulation5. The biological approach involves the use
of osteoconductive biomaterials6 and growth factors7. Wolff8 hypothesised that bone remodels in response to stress and
strain, due to the fact that the structure of bone adapts to changes in its stress environment. This process is also known as
mechanotransduction, which involves the conversion of a biophysical force into a biochemical response leading to changes in
gene expression and cellular adaptation. Static magnetic fields (SMFs) have been applied to stimulate bone healing, possibly
through the mechanism of mechanotransduction. It has been found that SMFs are capable of stimulating the osteogenesis of
osteoblasts, by influencing their proliferation, differentiation, extracellular matrix production and mineralisation9. Despite the
success of SMFs stimulations in several in vivo and in vitro studies, there remains two major concerns. Firstly, it is believed
that bone responds to dynamic rather than static loading, and the stimulation is related to the peak strain magnitude and loading
frequency10. Therefore in some of the cases, SMFs failed to demonstrate a positive effect on cell proliferation, differentiation
and other factors. Secondly, for the situations where SMFs successfully stimulate the osteogenesis process, the molecular
mechanisms of this phenomenon are not well understood.
In vitro models have been developed to study biological behaviour away from the intact living organism. Conventional in
vitro models refer to the testing system where cell monolayers are cultured on a stiff or flat surface (two-dimensional), however,
they differ from the natural tissue in many ways, such as structure, stiffness, cell/matrix interactions and attachments, and
the concentration of essential nutrients11. It is evident that many cells respond differently when cultured in 3D compared to
traditional 2D cultures, and often adopt more in vivo-like morphologies. Culturing cells in 3D radically alters the mechanical
signals from those provided in 2D, thus affecting cell-receptor ligation, intercellular signalling and critical cell behaviours such
as cellular migration. The 3D environment also influences the diffusion and adhesion of proteins, growth factors, and enzymes,
which ensures cell viability and can influence function12, 13. Maintaining cells in 3D systems, such as spheroids, micromass and
pellets, promotes progression of osteoblastic differentiation leading to osteoblast cell maturation14. Therefore, it is necessary
to develop a three-dimensional (3D) tissue/organ model to better mimic the natural environment for in vitro testing, which
provides an important alternative to both complex in vivo whole organism approaches and 2D culture with its spatial limitations.
Collagen hydrogels have an established track record as potential 3D models. Collagen is the most abundant protein found in
extracellular matrix (ECM), and provides desired properties such as an ECM-like scaffold, including water retention capacity,
nano/micro-porosity to allow cells to grow and arrange in 3D, biodegradability, and pore inter-connectivity to allow free flow
of oxygen and nutrients15–17. In addition, during tissue development and repair processes, collagen can interact directly with
cells and influence several cellular activities, including adhesion, growth, differentiation, mineralisation of ECM, as well as
the expression of growth factors and cytokines15, 18, 19. Due to these advantages, a large number of applications based on
collagen hydrogels can be found, such as nerve guide tubes for peripheral nerves20, scaffolds for connective tissues21, 3D
tumour models11, 22, hematopoietic niche models23 to study the biological behaviours of various cells and genes24–30.
However, conventional collagen hydrogels are low in collagen density (approximately 0.2 to 0.5 % of wet weight), with a
large excess of fluid (>98%)18. This results in poor mechanical properties as well as the lack of orientated architecture. In
order to construct a mechanically strong collagen based scaffold and maintain all useful properties, a novel approach known
as plastic compression (PC) has been developed by Brown et. al18, with many studies having demonstrated the suitability of
PC collagen scaffolds in tissue engineering applications, such as bone19, and cornea31. The PC process can be achieved by
compressing conventional collagen gels, leading to the controlled expulsion of interstitial fluid. PC allows the fabrication of
dense collagen constructs, which mimic the ECM fibrillary density, microstructure, and biological properties. With a single
plastic compression system, collagen density in the resultant model can increase to 11 - 18 %18. Furthermore, this construct
has been tested to last for at least 5 weeks in vivo32. As regards 3D scaffolds, PC collagen hydrogels have been investigated
to enhance the proliferation33, differentiation19 and mineralisation19, 34 of osteoblasts. Recent studies also focused on the
introduction of osteoconductive cues to further enhance the osteogenesis. Chitosan35 and bioactive glass particles36 have been
incorporated into PC systems to enhance cell differentiation and mineralisation.
Osteoblastic cell lines have been used extensively for in vitro investigations, with the advantages of unlimited cell numbers,
ease of culturing, reproducible growth characteristics and higher phenotypical stability as compared to primary cells37. Human
osteosarcoma cell line (MG-63) have been used as an experimental model to study a variety of different osteoblastic functions
such as adhesion, collagen synthesis, and osteocalcin production38. Recently, a number of studies have also successfully
employed MG-63 cells as a model to investigate cell behaviour under magnetic fields39, 40.
In this study, a novel multifunctional bio-mimetic 3D collagen model was developed and can be used as an in vitro platform
to study the mechanisms of magnetic stimulation on osteogenesis. Both internal (iron oxide nanoparticles) and an external
(SMFs) stimulus was introduced to the system to produce a range of cell-laden models. The collagen model was cultured
in a magnetic bio-reactor for up to 42 days to evaluate several biological behaviours of osteoblasts, including proliferation,
differentiation, mineralisation, gene expression and microstructure analysis.
Results
Microstructure of the Cell-Seeded Collagen Scaffolds
The microstructure of the cell loaded collagen scaffolds was examined after 1, 7 and 14 days using TEM, with fibrous collagen
structure and healthy attached cells shown (Figure 1a). The incorporation of IONPs can be identified, as being found inside the
cell in either agglomerated or separated state, close to the cell membrane or inside the collagen fibrils (Figure 1b and c). As can
be observed from Figure 1d and e, new matrix was synthesised by the cells after 14 days (with and without the exposure to SMFs).
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Cell Proliferation
The proliferation of MG-63 cells was assessed by alamarBlue assay with results shown in Figure 2a. From day 1, all treatments
stimulated cell proliferation significantly, and this effect continued until day 14. At day 7, the cell proliferation with treatments
almost doubled to that of the control, which indicates that all treatments had significant influences on cell proliferation, however,
no differences between each treatment were observed. At day 14, significant differences between SMFs, IONPs and the
combined on cell proliferation were observed. This demonstrates that employing SMFs or IONPs alone can only stimulate cell
proliferation up to 7 days, whereas by combining both factors, the effect can be extended until 14 days. Cellular responses of
compressed collagen gels seeded with MG-63 cell lines were obtained after 1, 3, 7 and 14 days of culture as shown in Figure
2c, d, e and f. Histology was employed to examine the cellular responses. By visualising the functional cells inside the collagen
scaffolds, the effects of SMFs and IONPs on cell proliferation examined by the AB assay can be validated. The cell numbers
have been analysed quantitatively as shown in Fig 2b. By employing SMFs alone, increased cell activity can be observed from
3 days but falls slightly after 14 days. This suggests that the SMFs alone can influence cell growth over short time periods but
are not effective for longer durations. The incorporation of IONPs can further the stimulation effects for 14 days. This suggests
that by incorporating IONPs, the effect of SMFs can be prolonged.
Cell Differentiation
Alkaline phosphatase (ALP) activities of collagen scaffolds with/without SMFs, and with/without the incorporation of IONPs
were determined. As shown in Fig 3a, no significant effect on ALP production was observed with SMFs, IONPs or the
combination, up to 14 days. On exposure to SMFs for 21 days, the ALP production of the cells was up-regulated significantly
under SMFs and the combination of SMFs and IONPs, whereas little difference was found with the incorporation of IONPs
alone. When further combining the effect of IONPs and SMFs, the ALP production was significantly stimulated when compared
to the SMFs (alone) and IONPs (alone) treatment.
Cell Mineralisation
ARS staining and quantification of mineralisation of cell-seeded collagen scaffolds are shown in Fig 3. At day 1, mineralisation
was not observed for all conditions. After 21 days, significant differences in the degree of mineralisation was identified, with
a higher level for scaffolds treated with SMFs. After 42 days, all samples were fully stained by ARS, indicating complete
mineralisation. Results indicated that SMFs can induce early mineralisation in vitro, with more significant simulation when
IONPs were incorporated. However, after 42 days, extraction levels remained unchanged when compared to the control,
indicating that the SMFs and IONPs were not able to promote mineralisation at this period.
Gene Expression : Real-time Polymerase Chain Reaction
To understand the responses of cell-seeded collagen scaffolds to IONPs and SMFs at the molecular level, the expression of
Runx2, ON, BMP-2 and BMP-4 were investigated by PCR. The expression of Runx2 normalised to GAPDH is illustrated in
Figure 4a. A 7 day treatment of SMFs alone had no significant effect on the expression of Runx2, whereas increased expression
can be found with the combination of SMFs and IONPs. After 14 days, the expression of Runx2 in the control sample increased
with increasing culture time. This demonstrates the collagen matrix can mediate the Runx2 expression during osteogenesis.
When compared to the controls, continuous treatment with both SMFs and IONPs enhanced the expression of Runx2, whereas
this effect cannot be observed with IONPs or SMFs alone. Significant enhancement between the combination condition and
SMFs (alone) was observed at 7 days, however, this effect was not continued to 14 days. The expression of ON normalised
to GAPDH is illustrated in Fig 4b. As can be observed, after 7 days, the level of ON expression in the samples treated with
IONPs, SMFs and both are higher than that in the control. Particularly, for SMFs and the combination treatment, the level of
expressions were the most significant. After 14 days, all samples with different conditions were increased to a similar level, and
there were no significant differences observed. This shows that SMFs and IONPs only enhanced the expression of ON within a
short time period, and have no significant influence for longer time periods. Figure 4c and d represent the expression of BMP-2
and BMP-4, respectively. When cultured for 7 days, the expression of BMP-2 in collagen, treated with IONPs or SMFs alone,
remained at a similar level to the control. However, when treated with both IONPs and SMFs, significant enhancement was
observed. Differences between the SMFs (alone), IONPs (alone) and the combination treatment were observed, indicating the
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stimulating effect of the combination of SMFs and IONPs. After 14 days, the expression of BMP-2 in the control sample did
not increase with time, whereas the effect of the combination of IONPs and SMFs on BMP-2 expression was significant. This
shows the combination treatment can stimulate the expression of BMP-2 in collagen scaffolds. As for BMP-4, at day 7, the
treatment with SMFs did not affect the expression significantly, whereas the incorporation of IONPs, and further exposure to
SMFs can up-regulate the expression of BMP-4. When further cultured for 14 days, the effect of IONPs was not significant
when compared to the control, as well as the SMFs, whereas a faster stimulation was observed when combining these two
together.
Discussion
The effects of SMFs, collagen matrix and the incorporation of IONPs on the osteogenesis of MG-63 cells have been studied.
By exposing to SMFs for 1, 3, 7 and 14 days, stimulating effects of SMFs alone on cell proliferation can be observed for up to 7
days. In the study of Cai et. al41, increased cell proliferation of MC3T3-E1 cells was observed when exposed under 100 mT
SMFs between 4 hours and 7 days of culture. However, cell proliferation decreased afterwards. The reason for not observing an
increase in proliferation after 7 days could be that bone responds to dynamic rather than static loadings, and this is related to the
peak strain magnitude and loading frequency10.
By further introducing IONPs to the SMFs treated collagen model, the stimulating effect can be extended for a longer
period (14 days). It has been shown that by introducing IONPs into polymer films under a 1 mT SMFs, the growth of bone cells
can be enhanced for up to 15 days42. Besides, when incorporating IONPs into polymer nano-fibrous membranes, the MG-63
cell proliferation increased with increasing seeding time and IONPs loading43. This can be caused by the interactions between
SMFs and IONPs. Magnetic fields induce a high magnetic gradient, which causes displacement of the particles along the
gradient vector, when the particles are associated with cells, and this leads to the production of compression and tensile forces
on the cell membrane44, resulting in a range of cellular responses including changes in intracellular calcium levels. Therefore
the biological behaviours of cells can be modified.
Cell differentiation investigations revealed that exposure to SMFs promoted ALP production from MG-63 after 21 days,
and the incorporation of IONPs further stimulated ALP production at a later stage (Fig 3a). ALP is one of the key substances
that indicate whether osteoblasts have entered the period of extracellular matrix development and maturation. Previous studies
have found that osteoblast-like cells expressed greater ALP levels after SMFs exposure41, 42, 45. Results suggested that the local
regulatory factors produced by SMFs treated cells, including collagen Type I, ALP and OP, were greater than those of the
untreated ones. The stimulation effect of SMFs on osteoblasts differentiation can contribute to the reorientation and distortion
of cell membranes and therefore modify the membrane properties, resulting in higher expression of growth factors associated
with differentiation hence leading to higher levels of ALP production.
SMFs, and the combination of SMFs and IONPs promoted mineralisation at day 21 when compared to the controls (shown
in Fig 3b). After 6 weeks, all samples reached similar levels of mineralisation, indicating the completion of cell mineralisation,
which is an essential process in osteogenesis. The transition from proliferation stage to matrix maturation is suggested by the
up regulation of genes associated with matrix development, such as collagen synthesis and ALP activity. Calcium accumulation
starts at the matrix development stage and reaches its maximum during the mineralisation stage. In vitro studies showed that
SMFs (290 mT) combined with osteogenic induction could enhance early extracellular calcium and bone mineralisation of
dental pulp cells46.
MG-63 cell lines have been used extensively for in vitro investigations, however, they have also been reported to have
atypical and variable behaviours47. Some studies have found that the proliferation rate of MG-63 cells are not very representative
of bone cell cultures. This cell line displays rapid cell growth without exhibiting contact inhibition, resulting in cell aggregation
and faster proliferation when compared to primary cells in vitro48. However, in the study of Czekanska et. al38, they observed
that although MG-63 has a much faster proliferation rate when compared to human osteoblasts, the growth kinetics of MG-63
was comparable to human osteoblasts in that the exponential phase was observed between days 2 and 6, followed by the plateau
phase from days 6 to 10. In this study, the rapid cell growth enabled us to get consistent results, in comparison with sometime
unpredictable primary cell models. Some studies questioned the capability of MG-63 cells to synthesis a correct ECM, as well
as ALP production48. However, in the study of Andrianarivo et. al49, they reported that by growing MG-63 cells on type I
collagen, an increased induction of alkaline phosphatase activity was observed. Similarly, in the current study, both external
SMFs and IONPs stimulated the ALP production of MG-63 cells in collagen, implying that the magnetic field and collagen
matrix could play an important role in osteoblastic differentiation and phenotypic expression in MG-63 cells, and potentially for
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primary cells. The ECM formation is encouraged under magnetic stimulations, this could potentially have a positive influence
on primary human osteoblasts.
From the observations in the current study, it was shown that the combination of SMFs and IONPs can induce and stimulate
the osteogenesis process, however, the mechanisms remain unclear. Osteogenesis is a complex process mediated by succession
of gene activation and expression, therefore an investigation at the molecular level was studied, including the effects on the
expression of several key genes, Runx2, ON, BMP-2 and BMP-4. Runx2 was up-regulated by the combination of IONPs
and SMFs exposure after 7 to 14 days of culture. Runx2 is the osteoblast-specific product of the Cbfa1 gene, and also a
transcription factor that is essential for osteoblast differentiation and bone formation. The expression of Runx2 can also cause
a stage dependent increase in the structural and functional proteins, for example, ALP, collagen type I, osteopontin, BSP
and osteocalcin in osteoblasts. Runx2 up-regulates the expression of bone matrix protein genes, allowing cells to acquire
the osteoblastic phenotype, hence promote in vitro and in vivo bone formation50, 51. For example, a study by Tsai et al52
demonstrated that, magnetic field induced significant higher expression of Runx2 of mesenchymal stem cells, accompanied
with the up-regulation of ALP, collagen type I and OC. Taken together, the results presented in the current study suggest
that SMFs exposure may induce an earlier osteogenic induction in MG-63 cell lines by modulating early osteoblastic gene
expression of Runx2, hence accelerating the osteogenesis. The expression of osteonectin was up regulated by the addition of
IONPs under SMFs after 7 days. However, after 14 days, the level of ON production in the control group reached a similar level
to the other treated samples. One possible explanation could be that collagen itself has a significant influence on the expression
of ON. ON is a glycoprotein in the bone that binds to both hydroxyapatite and collagen, therefore it plays a vital role in bone
mineralisation, cell-matrix interactions, and extracellular matrix regulation. When ON is bound to insoluble type I collagen,
the resultant complex binds synthetic apatite crystals and free calcium ions. One study suggested that ON is a tissue specific
protein that exhibits several interesting activities, such as linking the bone mineral and collagen phases, perhaps initiating active
mineralisation in normal skeletal tissue53. The IONPs incorporated model under SMFs was shown to enhance the expression of
ON over a 2 week period, which would explain the enhancement in the mineralisation level.
The osteoinductive capacity of BMP-2 and BMP-4 and their critical role as regulators of cell differentiation during fracture
repair have been identified54, 55. A lot of research has been focused on the stimulatory effects of magnetic fields on BMP-2
and BMP-4. Findings from the current study indicate that the expression of BMP-2 and BMP-4 can only be enhanced by the
combination of SMFs and IONPs over 14 days of culture. Both BMPs and Runx2 are able to stimulate osteoblast differentiation
and bone formation and their interrelationships have also been examined by Gersbach et. al56. The BMPs provide signals
that enhance Runx2 dependent transcription and at the same time, Runx2 provides information necessary for BMPs activity.
Therefore, the up-regulation of Runx2 and stimulation of the expression of BMPs, and the enhanced expression of BMPs can
further promote the production of Runx2.
The up-regulation of the Runx2, ON, BMP-2 and BMP-4 can be influenced by the modification of cell membrane properties.
Bilayer membranes, which are composed of a number of protein and lipid molecules, possess anisotropic diamagnetism in
nature57. Upon the exposure to SMFs, the phospholipid molecules of the membrane can be rotated by virtue of their collective
diamagnetic properties. This can possibly result in over deformation of the cellular membrane, modification of the biological
properties of embedded receptors in the membrane and, thereby altering the proliferation kinetics of the cells. Besides, it
is generally known that morphological and structural changes to the plasma membrane interfere with many functional and
structural features of the cells, leading, for example, to changes in cellular shape, cytoskeleton arrangement, ion flux, receptor
distribution58. To be more specific, the reorientation of the membrane matrix will influence the embedded ion channels,
most likely by producing some degree of deformity of their intra-membranous segment, hence leading to the activation of
calcium channels9. Therefore, by exposure to external SMFs and the incorporation of IONPs, the cell membrane properties and
cell/matrix interactions were influenced, leading to the up-regulation of Runx2, ON, BMP-2 and BMP-4 genes.
Conclusion
In this study, a bio-mimetic 3D collagen model has been developed, with the ability to incorporate cells and nanoparticles, and
can respond to external stimulations. MG-63 cell line and plastic compressed collagen model were successfully used as an in
vitro model with reproducible and consistent results. In conclusion, SMFs and IONPs together can enhance osteogenesis of
MG-63 cells when seeded inside the 3D collagen scaffold, by up-regulating the expression of Runx2, ON, BMP-2 and BMP-4,
which is a result of the cell/matrix interactions. The 3D model developed in the study can serve as a superior platform to further
investigate biological behaviours in vitro, and pave the way for further applications in tissue regeneration and regenerative
medicine.
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Methods
IONPs fabrication
IONPs were prepared by the co-precipitation method59. The method involves addition of a base (NaOH or NH4OH) to
ferric (Fe3+) and ferrous (Fe2+) chloride solutions under ambient pressure at an elevated temperature. Briefly, 5.41 g of
FeCl3·6H2O (Sigma-Aldrich) were mixed with 1.99 g of FeCl2·4H2O (Sigma-Aldrich), followed by an addition of 400 ml
NH4OH (Sigma-Aldrich). The resulting solution was left to grow for 30 mins and then washed 7 times by using centrifugation
and DI water. The suspension was mixed under sonication (Digital Sonifier 250, Branson Ultrasonics, Danbury, CT, USA) at
40 W in between each wash.
Formation of collagen gel
Acellular collagen gels were made by titrating the pH of rat tail type I collagen (First Link, Birmingham, UK. 2.10 mg/ml in
acetic acid). To make a total volume of 10 ml solution, 8 ml of acid soluble collagen was needed, with the addition of 1 ml
10 X DMEM (Gibco, Paisley, UK). The obtained solution was neutralised with 1M NaOH (Sigma-Aldrich), until a colour
change from yellow to cirrus pink was observed18. The neutralised gel requires the same pH value to ensure a consistency.
The remaining 1ml was made up with DMEM (Sigma-Aldrich) with and without cells. MG-63 cell line (Homo sapiens,
osteosarcoma, ATCC) were used in this study. This collagen gel was then set in a 24 well plate with an amount of 1 ml per well,
followed by incubation at 37◦C with 95 % relative humidity and 5 % CO2 for 30 minutes.
Plastic compression
The plastic compression protocol is modified from a study of Brown.et al.18. Briefly, collagen gels were set in 24-well plate and
covered by several layers of filter paper (Whatman grade I) on the top. A cylinder plunger roll (height=3.7 cm, diameter=1.5
cm) made by filter paper was laid on the top of each gel for 5 minutes. Extra weights can be added on top of the filter paper roll
to accelerate the process, with approximately 15 g per well. The extra liquid component is absorbed by the plunger and leaves a
thin layer of collagen gel with a thickness of 75-100 µm. IONPs can be embedded inside the collagen matrix at the point of
self-assembly. After the completion of plastic compression, the plunger roll was removed. Cell medium (1 ml) was then added
to each well immediately to keep the samples hydrated. The filter paper discs separating the plunger and the hydrogel can then
be removed at this point. Samples were then used or cultured as required.
Setting up exterior magnetic field
The exterior static magnetic fields (SMFs) was designed and simulated by computational software (ANSYS Maxwell) with
a magnetic field strength with the range of 72 - 144 mT (at the centre of the field, with a diameter of 1 cm). Neodymium
magnets were used as the sources of permanent magnets. A magnet holder was then designed via ANSYS SpaceClaim and
transferred to Magics 19 for selective laser sintering (SLS) (EOSINT P100), with a layer height of 0.1 mm. The material used
is biocompatible Nylon (PA 2200).
Alamar Blue Assay
The proliferation of MG-63 cell lines was assessed by using alamarBlue (Bio-Rad). Approximately 104 osteoblasts were seeded
into the compressed collagen scaffolds incorporated with nanoparticles. Cell seeded scaffolds were left for periods of 1, 3, 7
and 14 days in the incubator (37◦C, with 5 % CO2). 1 mL of DMEM was added to each well and replaced every two days.
At each time point, 100 µl of the reagent was added into each well. The plate was then incubated at 37◦C, with 5 % CO2
for a period of 2 h to allow the reaction. Afterwards, 100 µl of the supernatant was then removed from relevant wells (n=3)
and added to a 96-well plate (Falcon). Fluorescence was measured using a fluorescent plate reader (FLUstar OPTIMA) at
wavelengths of 544 nm (excitation) and 590 nm (emission).
Alkaline Phosphate Quantification
Approximately 104 cells were incorporated in 1 ml of collagen gel with various nanoparticles, followed by compression and
incubation at 37◦C, with 5 % CO2. DMEM changes were carried out every two days. After incubation for 7, 14 and 21
days, the scaffolds were removed into a 24-well plate and washed by PBS. Equal amounts (500 µl) of substrate reagent was
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added to each well. One tablet of 4-nitrophenyl phosphate disodium (SIGMA-A, Dorset, UK) was mixed with 8 mL 0.1
M Trizma Hydrochloride (3.94 g Tris in 500 ml DI water, pH=9.5) and 15 µL of 2M MgCl2 (9.521 g MgCl2 in 50 ml DI
water). The 24-well plate was left at room temperature for 15 mins for the reaction to take place. 100 µ l of 0.5 M NaOH (10 g
NaOH in 500 ml DI water) was then used to stop the reaction. Subsequently, 100 µl was removed from each well (n=3) and
transferred into a 96-well plate and the absorbance read at 405 nm (reference at 670 nm) using a plate reader (FLUstar OPTIMA).
Alizarin Red S Staining
The samples were examined after 1, 21 and 42 days of culture. Scaffolds were washed three times with PBS and fixed with
4% paraformaldehyde for routine wax embedding and sectioning. The sectioning process was done by a microtome with
a thickness of 5 um each. Sectioned samples were then been collected in hot water and dried for 30 mins. After drying,
specimens were de-waxed and cleaned in xyline for 2 mins, followed by several washes of 100% ethanol, 90% ethanol and 70%
ethanol. A protocol for staining has been developed for this study. Basically, 1g ARS dye was dissolved in 50 ml deionized
water and the pH was adjusted to 4.1 - 4.3 with 10% ammonium hydroxide. 1 ml of ARS solution was added on each slide
for 30 seconds and DI water was used to wash off the excess dye adsorbed on the scaffold surface. Presence of mineral
deposition (red-orange colour) was evaluated using a Nikon eclipse TE2000-5 optical microscope. For the quantification of
the level of mineralisation, the stained samples were desorbed with the use of 10% (w/v) cetylpyridinium chloride in 10 mM
sodium phosphate (pH 7.0). The dye was then collected and absorbance read at 540 nm using a plate reader (FLUstar OPTIMA).
Histology
Histology samples were prepared and stained with haemotoxylin and eosin (H & E). Three different sections were cut from
each sample and examined with two magnifications (10X and 40X). The cell numbers in each image were counted and plotted
with average number and standard deviation (n=3). Images were analysed by image analysis software (Image J) to quantify
cell numbers. Histology specimens were fixed with 4% paraformaldehyde for routine wax embedding and sectioning. The
sectioning process was done using a microtome with a thickness of 5 µm. Sectioned samples were then collected in hot water
and dried for 30 mins. After drying, specimens were de-waxed and cleaned in xyline for 2 mins, followed by several washes
of 100% ethanol, 90% ethanol and 70% ethanol. After air drying, H&E staining was then used for staining the samples for
30 seconds each, followed by rinsing under running water. After staining, specimens were dehydrated by 70% ethanol, 90%
ethanol and 100% ethanol and xyline for future storage, with cover slips mounted on top.
Microstructure Examination by TEM
A Philips CM120 Transmission Electron Microscope was used to examine the cellular structure of cell-seeded collagen tissues.
Cell seeded collagen scaffolds were stabilised in Karnovsky’s fixative (2.5% glutaraldehyde/ 2% paraformaldehyde/ 0.1 M
PBS) to preserve structure details, follow by dehydration and then infiltrated with a liquid resin, which is hardened by gentle
heat. Resin blocks containing the tissue can therefore be sectioned and stained with heavy metal solutions for observation in the
TEM. Firstly, pieces of the fixed tissue were placed in screw cap microtubes with PBS and washed 3 times of 10 mins each.
Secondly, the PBS was discarded and the samples were postfixed in 1% osmium tetroxide solution for 1 hour at 4 ◦C. Then
osmium solution was removed with a pipette. Samples was washed 3 x 15 mins with distilled water, followed by dehydration
through graded ethanol solutions of 30%, 50%, 70% and 90% with 2x 15 mins each, and finally in 100% ethanol 3x 15 min.
The infiltration with liquid resin was achieved by infiltrating the tissue in 40% resin for 3 hours, overnight in 60% resin and
then 100% resin for 6 hours at room temperature. After final infiltration, tissues were placed in labelled embedding moulds
with fresh resin and polymerised in the oven at 70 ◦C overnight to be examined. The specimens were sectioned into 70nm and
stained in uranyl acetate for 2 hrs, followed by lead citrate for 5 mins.
RNA Extraction
RNeasy Mini Kit (Qiagen 74104 and 74106) was used to extract the RNA from the samples. Firstly, 350 µl Buffer RLT was
added to the sample in a micro-centrifuge tube and mixed well to release cells. Samples were stored at -80 ◦C if not used
immediately. Secondly, 250 µl ethanol (96 - 100 %) was added to the diluted RNA and mixed well by pipetting, followed by
transferring the samples (700 µ l) to an RNeasy Mini spin column placed in a 2 ml collection tube. 350 µ l of Buffer RW1 was
then added to the RNeasy column. 10 µl DNase I stock solution was added to 70 µl Buffer RDD. This was mixed well by
gently inverting the tube. Then the DNase I incubation mix (80 µl) was directly added to the RNeasy column membrane and
left for 15 mins at 20-30 ◦C. Then 350 µl Buffer RW1 was added to the column, followed by 2× of 500 µl Buffer RPE (with
the addition of 4 volumes of 96 - 100 % ethanol for a working solution) to wash the membrane. Centrifugation at ≥ 8000 × g
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for 15 s was needed in between each step. Finally, the RNeasy spin column was placed in a new 1.5 ml collection tube with an
addition of 40 µl RNase-free water directly to the spin column membrane, centrifuged for 1 mins at ≥ 8000 × g to elute the
RNA. The isolated RNA was quantified by a Nanodrop spectrometer.
Reverse Transcription with Elimination of Genomic DNA for Quantitative, Real-Time PCR
To eliminate the genomic DNA, 2 µ l of buffer GE, 50 ng of template RNA with variable RNase-free water were used to make a
total volume of 10 µ l reaction. The samples were incubated for 5 mins at 42 ◦C and then placed on ice immediately. Then the
reverse transcriptase master mix was prepared by adding 4 µl 5× buffer BC3, 2 µl of RE3 Reverse Transcriptase Mix and 4
µl of RNase-free water to make a total volume of 10 µl solution. This master mix was incubated at 42 ◦C for 5 mins. Then
the template RNA and reverse transcriptase master were mixed together, followed by incubation at 42 ◦C for 15 mins and 95
◦C for 5 mins. Then 30 µl RNase-free water was added to each reaction and mixed by pipetting up and down several times.
The RT SYBR Green Mastermix was prepared as below. 0.5 µl of 10 µ mol of forward primer and 0.5 µl of 10 µ mol of
reverse primers were added together with 4 µ l of SYBR Green and 3 µ l of RNase-free water to make a 8 µ l solution. Finally, 2
µl of the cDNA and 8 µl of the SYBR Green Master Mix was added into one well to make one reaction. The primers used
are: GAPDH: 5’ TGCACCACCAACTGCTTAGC 3’ and 5’ GGCATGGACTGTGGTCATGAG 3’(60); Runx2: CCAACC-
CACGAATGCACTATC 3’ and 5’ TAGTGAGTGGTGGCGACATAC 3’ (61); Osteonectin: ATTGACGGGTACCTCTCCCA
3’ and 5’ GAAAAAGCGGGTGGTGCAAT 5’; BMP-2: 5’,TTTCAATGGACGTGTCCCCG 3’ and 5’ AGCAGCAACGC-
TAGAAGACA 3’ and BMP-4 : 5’ CGTCCAAGCTATCTCGAGCC 3’ and 5’ CGGAATGGCTCCATAGGTCC 3’(designed
by using Primer-BLAST62). The reaction conditions were as follows: incubation at 95 ◦C for 2 mins, denaturation at 95 ◦C
for 10s, annealing at 60 ◦C for 5s and polymerisation at 72 ◦C for 25s, followed by a final extension at 76 ◦C for 1s, for 45
cycles. Quantitative analysis was performed according to the ABI protocol. The threshold cycle (Ct) value was calculated
from amplification plots. The dCt value for each sample was obtained by subtracting the Ct values of the housekeeping gene
GAPDH. The data are represented for triplicate readings.
Statistical Analysis
The experiments of biological property evaluation were performed in triplicate. The results are represented as mean ± standard
deviation for n=3. Statistical analysis was carried out by analysis of variance (ANOVA) to determine the presence of any
significant differences between groups, and significant level was set at p < 0.05.
Data Availability Statement
The datasets generated during and/or analysed during the current study are available from the corresponding author on
reasonable request.
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Figure 1. (a) Microstructure of cell loaded collagen scaffolds examined under TEM. Cells are surrounded by the collagen
matrix, the collagen fibrils show no preferred direction around cells under control condition. IONPs can be identified (b) in the
collagen matrix and (c) close to cell membranes. After 14 days, new matrix was synthesised by the cells (d) without SMFs and
(e) with SMFs. Both conditions can lead to matrix synthesis after 14 days, with no significant difference.
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Figure 2. (a) A comparison of cell proliferation of MG-63 cells when cultured within collagen scaffolds with/without the
incorporation of IONPs, with (M) and without the exposure of SMFs. Cell proliferation can be enhanced under SMFs with the
incorporation of IONPs, indicating a stimulating effect. (b) A comparison of cell number of MG-63 cell lines from histology
for IONPs with and without SMFs. The cell number represents the average from three sections of one sample. By
incorporating additional IONPs, the cell proliferation can be further enhanced. The cellular responses of MG-63 cells when
cultured in PC collagen scaffolds were also examined by histology, with no SMFs and no IONPs (c), SMFs (d), IONPs (e) and
SMFs and IONPs (f). Scale bar = 100 µm (n=3, ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001, ∗∗∗∗p<0.0001).
13/15
Figure 3. (a) A comparison of ALP production of MG-63 cells when cultured within collagen scaffolds with/without the
incorporation of IONPs, with (M) and without the exposure of SMFs. (b) A comparison of cell mineralisation by extracting and
quantifying ARS staining from scaffolds treated with and without SMFs exposure. Cell-loaded collagen scaffolds were
incorporated with IONPs with a concentration of 100 µg/ml, results were collected at 1, 21 and 42 days of culture time. (c)
ARS of collagen scaffolds with the absence of SMFs and IONPs, (d) with SMFs, (e) with IONPs and (f) with SMFs and IONPs.
Scale bar = 100 µm (n=3, ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001, ∗∗∗∗p<0.0001).
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Figure 4. Relative expression of (a) Runx2, (b) osteonectin, (c) BMP-2 and (d) BMP-4 normalised to GAPDH after 7 and 14
days of culture (n=3, ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001, ∗∗∗∗p<0.0001).
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